Dynavax Technologies Corporation – LSE:0IDA.L
Dynavax Technologies stock price today
Dynavax Technologies stock price monthly change
Dynavax Technologies stock price quarterly change
Dynavax Technologies stock price yearly change
Dynavax Technologies key metrics
Market Cap | 1.69B |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | 0.07 |
Revenue | 236.14M |
EBITDA | 13.09M |
Income | 9.22M |
Revenue Q/Q | 8.23% |
Revenue Y/Y | -63.98% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | 5.55% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeDynavax Technologies stock price history
Dynavax Technologies stock forecast
Dynavax Technologies financial statements
| Jun 2023 | 60.24M | 3.43M | 5.69% |
|---|---|---|---|
| Sep 2023 | 69.51M | 14.29M | 20.56% |
| Dec 2023 | 55.59M | 219K | 0.39% |
| Mar 2024 | 50.79M | -8.72M | -17.17% |
| Sep 2025 | 94.16M | 14.51M | 15.41% |
|---|---|---|---|
| Oct 2025 | 92.46M | 11.14M | 12.05% |
| Dec 2025 | 75.44M | 2.17M | 2.88% |
| Mar 2026 | 88.25M | 11.08M | 12.56% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 936432000 | 359.22M | 38.36% |
|---|---|---|---|
| Sep 2023 | 972933000 | 368.01M | 37.83% |
| Dec 2023 | 997096000 | 375.02M | 37.61% |
| Mar 2024 | 986565000 | 368.08M | 37.31% |
| Jun 2023 | 28.04M | 24.72M | -294K |
|---|---|---|---|
| Sep 2023 | 31.12M | -106.07M | 2.99M |
| Dec 2023 | 13.76M | -20.24M | 1.77M |
| Mar 2024 | -16.67M | 2.83M | -4.20M |
Dynavax Technologies alternative data
| Aug 2023 | 351 |
|---|---|
| Sep 2023 | 351 |
| Oct 2023 | 351 |
| Nov 2023 | 351 |
| Dec 2023 | 351 |
| Jan 2024 | 351 |
| Feb 2024 | 351 |
| Mar 2024 | 408 |
| Apr 2024 | 408 |
| May 2024 | 408 |
| Jun 2024 | 408 |
| Jul 2024 | 408 |
Dynavax Technologies other data
| Patent |
|---|
Grant Filling date: 9 Nov 2017 Issue date: 28 Jun 2022 |
Application Filling date: 16 Aug 2021 Issue date: 3 Feb 2022 |
Application Filling date: 18 Jun 2021 Issue date: 7 Oct 2021 |
Grant Filling date: 2 Mar 2020 Issue date: 21 Sep 2021 |
Application Filling date: 21 Aug 2020 Issue date: 1 Jul 2021 |
Grant Filling date: 26 May 2016 Issue date: 25 Aug 2020 |
Grant Utility: Cleavable conjugates of TLR7/8 agonist compounds, methods for preparation, and uses thereof Filling date: 13 Nov 2018 Issue date: 28 Jul 2020 |
Application Filling date: 2 Mar 2020 Issue date: 25 Jun 2020 |
Grant Filling date: 21 Aug 2018 Issue date: 14 Apr 2020 |
Grant Filling date: 20 Apr 2018 Issue date: 4 Feb 2020 |
| Insider | Compensation |
|---|---|
| Mr. David F. Novack (1962) Pres & Chief Operating Officer | $697,270 |
| Dr. Robert Janssen (1954) Chief Medical Officer & Senior Vice President of Clinical Devel., Medical and Regulatory Affairs | $666,130 |
| Mr. Michael S. Ostrach (1952) Chief Financial Officer, Chief Bus. Officer & Senior Vice President | $662,540 |
| Mr. Ryan Spencer (1978) Chief Executive Officer & Director | $545,590 |
Ms. Cecilia Vitug Vice President of HR | |
Mr. Donn Casale Vice President of Sales & Marketing | |
Mr. Jeff P. Coon Senior Vice President of HR & Corporation Services | |
Mr. Steven N. Gersten Chief Ethics & Compliance Officer, Senior Vice President, Gen. Counsel and Sec. | |
Ms. Heather Rowe Vice President of Investor Relations & Corporation Communications | |
| Mr. Justin Burgess Principal Accounting Officer & Controller |
-
What's the price of Dynavax Technologies stock today?
One share of Dynavax Technologies stock can currently be purchased for approximately $13.88.
-
When is Dynavax Technologies's next earnings date?
Unfortunately, Dynavax Technologies's (0IDA.L) next earnings date is currently unknown.
-
Does Dynavax Technologies pay dividends?
No, Dynavax Technologies does not pay dividends.
-
How much money does Dynavax Technologies make?
Dynavax Technologies has a market capitalization of 1.69B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 67.86% to 232.28M US dollars.
-
What is Dynavax Technologies's stock symbol?
Dynavax Technologies Corporation is traded on the LSE under the ticker symbol "0IDA.L".
-
What is Dynavax Technologies's primary industry?
Company operates in the Healthcare sector and Medical - Pharmaceuticals industry.
-
How do i buy shares of Dynavax Technologies?
Shares of Dynavax Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Dynavax Technologies's key executives?
Dynavax Technologies's management team includes the following people:
- Mr. David F. Novack Pres & Chief Operating Officer(age: 63, pay: $697,270)
- Dr. Robert Janssen Chief Medical Officer & Senior Vice President of Clinical Devel., Medical and Regulatory Affairs(age: 71, pay: $666,130)
- Mr. Michael S. Ostrach Chief Financial Officer, Chief Bus. Officer & Senior Vice President(age: 73, pay: $662,540)
- Mr. Ryan Spencer Chief Executive Officer & Director(age: 47, pay: $545,590)
- Ms. Cecilia Vitug Vice President of HR
- Mr. Donn Casale Vice President of Sales & Marketing
- Mr. Jeff P. Coon Senior Vice President of HR & Corporation Services
- Mr. Steven N. Gersten Chief Ethics & Compliance Officer, Senior Vice President, Gen. Counsel and Sec.
- Ms. Heather Rowe Vice President of Investor Relations & Corporation Communications
- Mr. Justin Burgess Principal Accounting Officer & Controller
-
How many employees does Dynavax Technologies have?
As Jul 2024, Dynavax Technologies employs 408 workers.
-
When Dynavax Technologies went public?
Dynavax Technologies Corporation is publicly traded company for more then 7 years since IPO on 29 Jan 2018.
-
What is Dynavax Technologies's official website?
The official website for Dynavax Technologies is dynavax.com.
-
Where are Dynavax Technologies's headquarters?
Dynavax Technologies is headquartered at 2100 Powell Street, EmeryVille, CA.
-
How can i contact Dynavax Technologies?
Dynavax Technologies's mailing address is 2100 Powell Street, EmeryVille, CA and company can be reached via phone at +51 08485100.
Dynavax Technologies company profile:
Dynavax Technologies Corporation
dynavax.comLSE
408
Medical - Pharmaceuticals
Healthcare
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.
EmeryVille, CA 94608
:
ISIN: US2681582019
:
